| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 79, 537-541, Copyright © 1994 by Endocrine Society
ARTICLES |
G Marin, HM Domene, KM Barnes, BJ Blackwell, FG Cassorla and GB Cutler Jr
Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.
To determine the effects of puberty and estrogen priming on the GH response to standardized treadmill exercise and arginine-insulin in normal boys and girls, we performed tests in 84 normal children (41 girls and 43 boys) representing all stages of puberty. A subset of the prepubertal children received the tests twice, with or without the administration of ethinyl estradiol (40 micrograms/m2 daily) for 2 days before the tests. The peak GH response to the three tests increased significantly with pubertal stage (r = 0.57; P < 0.0001), but did not differ between boys and girls at the same stage. With advancing puberty, the percentage of normal children who failed to attain a GH level greater than 7 micrograms/L during any of the three tests declined from 61% at pubertal stage 1 to 44% at stage 2, 11% at stage 3, and 0% at stages 4 and 5. Administration of estrogen to the prepubertal subjects raised the normal range for the peak GH response to the three tests from 1.9-20.3 to 7.2-40.5 micrograms/L. We conclude that both puberty and estrogen administration significantly increase the peak GH response to exercise, arginine, or insulin in normal subjects. Moreover, the conventional criterion that the peak GH response to three stimulation tests should exceed 7 micrograms/L was applicable in our study only to subjects who had attained pubertal stage 4 or 5 or who had received estrogen administration.
This article has been cited by other articles:
 |
|
 |
|
  A. Secco, N. di Iorgi, F. Napoli, E. Calandra, M. Ghezzi, C. Frassinetti, S. Parodi, M. R. Casini, R. Lorini, S. Loche, et al. The Glucagon Test in the Diagnosis of Growth Hormone Deficiency in Children With Short Stature Younger than 6 Years J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4251 - 4257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G Rosenfeld Pharmacogenomics and pharmacoproteomics in the evaluation and management of short stature Eur. J. Endocrinol., August 1, 2007; 157(suppl_1): S27 - S31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Lebenthal, G. Gat-Yablonski, B. Shtaif, A. Padoa, M. Phillip, and L. Lazar Effect of Sex Hormone Administration on Circulating Ghrelin Levels in Peripubertal Children J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 328 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Leger, S. Danner, D. Simon, C. Garel, and P. Czernichow Do All Patients with Childhood-Onset Growth Hormone Deficiency (GHD) and Ectopic Neurohypophysis Have Persistent GHD in Adulthood? J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 650 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Ross, D. E. Sandberg, S. R. Rose, E. W. Leschek, J. Baron, J. J. Chipman, F. G. Cassorla, C. A. Quigley, B. J. Crowe, K. Roberts, et al. Psychological Adaptation in Children with Idiopathic Short Stature Treated with Growth Hormone or Placebo J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4873 - 4878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-C. Leung, G. Johannsson, G. M. Leong, and K. K. Y. Ho Estrogen Regulation of Growth Hormone Action Endocr. Rev., October 1, 2004; 25(5): 693 - 721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. W. Leschek, S. R. Rose, J. A. Yanovski, J. F. Troendle, C. A. Quigley, J. J. Chipman, B. J. Crowe, J. L. Ross, F. G. Cassorla, W. F. Blum, et al. Effect of Growth Hormone Treatment on Adult Height in Peripubertal Children with Idiopathic Short Stature: A Randomized, Double-Blind, Placebo-Controlled Trial J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3140 - 3148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Gleeson, H. R. Gattamaneni, L. Smethurst, B. M. Brennan, and S. M. Shalet Reassessment of Growth Hormone Status Is Required at Final Height in Children Treated with Growth Hormone Replacement after Radiation Therapy J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 662 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Ayling More guidance on growth hormone deficiency J. Clin. Pathol., February 1, 2004; 57(2): 123 - 125. [Full Text] [PDF]
|
|
|
|
|
|
H. R. Boquete, P. G. V. Sobrado, H. L. Fideleff, A. M. Sequera, A. V. Giaccio, M. G. Suarez, G. F. Ruibal, and M. Miras Evaluation of Diagnostic Accuracy of Insulin-Like Growth Factor (IGF)-I and IGF-Binding Protein-3 in Growth Hormone-Deficient Children and Adults Using ROC Plot Analysis J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4702 - 4708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Lee, S. D. Chernausek, A. C. S. Hokken-Koelega, and P. Czernichow International Small for Gestational Age Advisory Board Consensus Development Conference Statement: Management of Short Children Born Small for Gestational Age, April 24-October 1, 2001 Pediatrics, June 1, 2003; 111(6): 1253 - 1261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Carel, E. Ecosse, M. Nicolino, M. Tauber, J. Leger, S. Cabrol, I. Bastie-Sigeac, J.-L. Chaussain, and J. Coste Adult height after long term treatment with recombinant growth hormone for idiopathic isolated growth hormone deficiency: observational follow up study of the French population based registry BMJ, July 13, 2002; 325(7355): 70 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Weintrob, D. Cohen, Y. Klipper-Aurbach, Z. Zadik, and Z. Dickerman Decreased Growth During Therapy With Selective Serotonin Reuptake Inhibitors Arch Pediatr Adolesc Med, July 1, 2002; 156(7): 696 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Coutant, S. Rouleau, F. Despert, N. Magontier, D. Loisel, and J.-M. Limal Growth and Adult Height in GH-Treated Children with Nonacquired GH Deficiency and Idiopathic Short Stature: The Influence of Pituitary Magnetic Resonance Imaging Findings J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4649 - 4654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. MartÍnez, H. M. Domené, M. G. Ropelato, H. G. Jasper, P. A. Pennisi, M. E. Escobar, and J. J. Heinrich Estrogen Priming Effect on Growth Hormone (GH) Provocative Test: A Useful Tool for the Diagnosis of GH Deficiency J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4168 - 4172. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Hasegawa, K. Fujii, M. Yamada, Y. Igarashi, K. Tachibana, T. Tanaka, K. Onigata, Y. Nishi, S. Kato, and T. Hasegawa Identification of Novel Human GH-1 Gene Polymorphisms that Are Associated with Growth Hormone Secretion and Height J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1290 - 1295. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. L. Hintz, K. M. Attie, J. Baptista, A. Roche, and The Genentech Collaborative Group Effect of Growth Hormone Treatment on Adult Height of Children with Idiopathic Short Stature N. Engl. J. Med., February 18, 1999; 340(7): 502 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. S. Drop, W. J. de Waal, and S. M. P. F. de Muinck Keizer-Schrama Sex Steroid Treatment of Constitutionally Tall Stature Endocr. Rev., October 1, 1998; 19(5): 540 - 558. [Abstract] [Full Text]
|
|
|
|
|
|
S. M. Shalet, A. Toogood, A. Rahim, and B. M. D. Brennan The Diagnosis of Growth Hormone Deficiency in Children and Adults Endocr. Rev., April 1, 1998; 19(2): 203 - 223. [Abstract] [Full Text]
|
|
|
|
|
|
R. Coutant, J.-C. Carel, M. Letrait, C. Bouvattier, P. Chatelain, J. Coste, and J.-L. Chaussain Short Stature Associated with Intrauterine Growth Retardation: Final Height of Untreated and Growth Hormone-Treated Children J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1070 - 1074. [Abstract] [Full Text]
|
|
|
|
|
|
J.-C. Carel, J.-P. Tresca, M. Letrait, J.-L. Chaussain, Y. Lebouc, J.-C. Job, and J. Coste Growth Hormone Testing for the Diagnosis of Growth Hormone Deficiency in Childhood: A Population Register-Based Study J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2117 - 2121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Cemeroglu, A. L. Barkan, G. B. Kletter, I. Z. Beitins, and C. M. Foster Changes in Serum Immunoreactive and Bioactive Growth Hormone Concentrations in Boys with Advancing Puberty and in Response to a 20-Hour Estradiol Infusion J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2166 - 2171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hornum, D. M. Cooper, J. A. Brasel, A. Bueno, and K. E. Sietsema Exercise-induced changes in circulating growth factors with cyclic variation in plasma estradiol in women J Appl Physiol, June 1, 1997; 82(6): 1946 - 1951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Juul, K. W. Kastrup, S. A. Pedersen, and N. E. Skakkebak Growth Hormone (GH) Provocative Retesting of 108 Young Adults with Childhood-Onset GH Deficiency and the Diagnostic Value of Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein-3 J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1195 - 1201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Loche, A. Colao, M. Cappa, J. Bellone, G. Aimaretti, G. Farello, A. Faedda, G. Lombardi, R. Deghenghi, and E. Ghigo The Growth Hormone Response to Hexarelin in Children: Reproducibility and Effect of Sex Steroids J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 861 - 864. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
